Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1127970

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Doctors: Equal Pay
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to evaluate the potential effect on the gender pay gap in medicine of the Government’s decision not to include (a) consultants and (b) specialist and associate speciality doctors in the NHS shared parental leave entitlement implemented in April 2019.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	256964
answer	answer is ministerial correction date of answer 30/05/2019 answer text <p>The shared parental leave arrangements introduced in April 2019 were part of the Agenda for Change pay and contract reform agreement and enacted via changes to the National Health Service Terms and Conditions of Service Handbook.</p><p>The provisions were extended to doctors and dentists in training, by virtue of the fact that their contractual arrangements mirror certain non-pay schedules from the NHS Handbook.</p><p>The current terms and conditions for consultants and specialty and associate specialist (SAS) doctors do not share these same schedules and therefore the changes do not automatically apply to these staff.</p><p>We firmly believe that all members of NHS staff should be treated equally. Established routes for contractual changes are via NHS Employers. Medical trades unions have been invited by NHS Employers to adopt the same non-pay schedules from the NHS Handbook for consultant and SAS doctors as have already been adopted by doctors and dentists in training, including those relating to shared parental leave.</p><p>An evaluation on the potential effect on the gender pay gap in medicine of not including consultants and specialty and associate specialist doctors in the NHS shared parental leave entitlement has not been planned.</p><p>The Department has commissioned an independent review into the gender pay gap in medicine, chaired by Professor Dame Jane Dacre. The review, which commenced in April 2018, is currently examining qualitative and quantitative evidence which will help identify the impact of cultural, practical and psychological issues that contribute to the gender pay gap in medicine.</p><p>The evidence collected and examined will go on to produce a series of implementable recommendations for publication in September 2019.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 256965 question first answered 30/05/2019 10:36:06 answering member 1585 label Biography information for Stephen Hammond
tabling member	1436 label Biography information for Paul Farrelly

1127994

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Prescriptions
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what response they have made of the report by Asthma UK Paying to breathe: Why unfair asthma prescription charges must be stopped; and whether they have responded, or intend to respond, to that report.
tabling member printed	Lord Hunt of Kings Heath
uin	HL15879
answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>I recently met with Asthma UK and discussed their report. Departmental officials continue to engage with Asthma UK on the issues raised in the meeting.</p><p>The Government has no plans to review the current system of medical exemptions from prescription charges. Extensive arrangements are already in place to help people access National Health Service prescriptions. These include a broad range of NHS prescription charge exemptions.</p><p>To support those with the greatest need who do not qualify for an exemption, the cost of the prescription pre-payment certificates has been frozen for another year. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 05/06/2019 14:08:14 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1127995

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the proportion of inhaler users who are (1) not getting their inhaler technique checked, and (2) not using their inhaler properly.
tabling member printed	Lord Hunt of Kings Heath
uin	HL15880
answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>Respiratory disease is a clinical priority within the NHS Long Term Plan.</p><p>The NHS Long Term Plan sets out how the National Health Service will take action in a number of areas, including managing inhaled medications. Pharmacists in primary care networks will undertake a range of medicine reviews, including educating patients on the correct use of inhalers and contributing to multidisciplinary working.</p><p>Data on inhaler technique is not routinely collected in England. The national asthma and chronic obstructive pulmonary disease audit programme will include data on asthma from 2019. This will include data on inhaler technique and will enable monitoring in England.</p><p> </p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15881 HL15882 question first answered 05/06/2019 14:17:11 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1127996

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact on patients of not using their asthma inhalers correctly.
tabling member printed	Lord Hunt of Kings Heath
uin	HL15881
answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>Respiratory disease is a clinical priority within the NHS Long Term Plan.</p><p>The NHS Long Term Plan sets out how the National Health Service will take action in a number of areas, including managing inhaled medications. Pharmacists in primary care networks will undertake a range of medicine reviews, including educating patients on the correct use of inhalers and contributing to multidisciplinary working.</p><p>Data on inhaler technique is not routinely collected in England. The national asthma and chronic obstructive pulmonary disease audit programme will include data on asthma from 2019. This will include data on inhaler technique and will enable monitoring in England.</p><p> </p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15880 HL15882 question first answered 05/06/2019 14:17:11 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1127997

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what action they are taking to introduce national guidelines to ensure that everyone with asthma should get their inhaler technique checked annually as part of their asthma review.
tabling member printed	Lord Hunt of Kings Heath
uin	HL15882
answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>Respiratory disease is a clinical priority within the NHS Long Term Plan.</p><p>The NHS Long Term Plan sets out how the National Health Service will take action in a number of areas, including managing inhaled medications. Pharmacists in primary care networks will undertake a range of medicine reviews, including educating patients on the correct use of inhalers and contributing to multidisciplinary working.</p><p>Data on inhaler technique is not routinely collected in England. The national asthma and chronic obstructive pulmonary disease audit programme will include data on asthma from 2019. This will include data on inhaler technique and will enable monitoring in England.</p><p> </p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15880 HL15881 question first answered 05/06/2019 14:17:11 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1128009

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Children
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what processes are in place to safeguard children with chronic fatigue syndrome and other disorders whose parents have enrolled them on Lightning Process courses; and what evaluation has been undertaken of the (1) benefits, and (2) harms, to those children who have participated in such courses.
tabling member printed	The Countess of Mar
uin	HL15894
answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>The Lightning Process (LP) is not offered as a part of the chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) standard treatments on the National Health Service. Subject to the nature of the safeguarding concerns, issues should be directed to the relevant professional regulator, should the practitioner be a member of a registered profession; the local authority (trading standards office or children’s service), if false claims are being made about the effectiveness of the treatment or welfare of a child is a concern; or the police, if a crime is involved.</p><p>The LP involves a course of three half-days of training aiming to teach participants how to use their brain to improve their body's health.</p><p>A randomised controlled trial with 100 adolescents aged 12-18 was undertaken by researchers in Bristol. Participants were randomised into two groups: those who received standard CFS/ME treatment and those who received the standard treatment plus the LP.</p><p>Researchers found those who received the LP had better physical function, were less tired and less anxious after six months. At 12 months, they had further improvement in physical function, and improved depression scores and school attendance. This research trial had several limitations as set out in the peer reviewed journal article. This was a very small trial and so it would need to be repeated in a much larger group to demonstrate more generalisable findings. Participants were not blinded so their self-reported outcomes might have been biased, for example participants may have been more likely to report positive outcomes because they knew they were getting additional therapy in the LP group. Of all those eligible to participate in the trial, fewer than 30% agreed to take part. Participants in the trial did not have any serious adverse events attributable to either LP or usual care. LP therapy was given in addition to the usual CFS/ME care as a no-treatment control group was not deemed ethical, therefore it cannot be suggested as a replacement for current specialised medical care.</p><p>Independent ethical review ensures that participant safety is at the centre of all research. In the United Kingdom, review by an ethics committee is one of a series of safeguards intended to protect the people taking part in the research. The operating procedure for trials in the UK has inbuilt safeguards designed to protect patients from harm in the event an intervention is ineffective or potentially harmful. Participants are free to withdraw from a study at any time.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 05/06/2019 16:40:17 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1861 label Biography information for The Countess of Mar

1127283

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage fairer pricing by pharmaceutical companies for drugs supplied to the NHS.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255651
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The 2019 Voluntary Scheme for Branded Medicines Pricing and Access, and the statutory scheme for branded medicines pricing, work together to control the cost of branded medicines to the National Health Service and ensure it stays within affordable limits.</p><p> </p><p>The 2019 Voluntary Scheme began on 1 January 2019 and will run for five years until the end of 2023. The Voluntary Scheme aims to provide stability and predictability for all parties in terms of the United Kingdom’s branded medicines expenditure and the medicines pricing and access environment for the period 2019 to 2023. It also aims to achieve a balance between patient access, affordability and supporting the development of innovative new medicines, including support for small companies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:30:06 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1127317

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of young people developing bowel cancer.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255652
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Obesity and poor diet are risk factors for bowel cancer in young people.</p><p>The second chapter of the world-leading childhood obesity plan was published in June 2018. This builds on the real progress made since the publication of chapter one in 2016, particularly in reformulation of the products our children eat and drink most. In chapter two we have set a bold ambition to halve childhood obesity by 2030 and significantly reduce the gap in obesity between children from the most and least deprived areas by 2030.</p><p>Many of the measures in both chapters of the plan will have an impact on tackling obesity across all age groups. These include the soft drinks industry levy, sugar reduction and wider calorie reformulation programme, restricting promotions and calorie labelling in restaurants which will improve our eating habits and reduce the amount of sugar we consume.</p><p>‘Childhood obesity: a plan for action, chapter 2’ is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2" target="_blank">www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:24:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1127327

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diffuse Intrinsic Pontine Glioma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of access to NHS support for sufferers of diffuse intrinsic pontine glioma.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	255692
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>No specific assessment has been made by the Department at this time.</p><p>Care for children with Diffuse Intrinsic Pontine Glioma (DIPG) is co-ordinated and provided by Children’s Cancer Principal Treatment Centres (PTCs) working in conjunction with Paediatric Oncology Shared Care Units. Children’s Cancer PTCs are responsible for planning and delivering treatment for children with DIPG as well as ensuring these children can access wider support services such as psychology services, specialist play services and other therapies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:25:19 answering member 4455 label Biography information for Seema Kennedy
tabling member	4571 label Biography information for Gill Furniss

1127168

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Urinary Tract Infections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce unplanned hospital admissions resulting from urinary tract infections.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	255355
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>In England, it is the responsibility of National Health Service commissioners to make decisions on individual treatments for urinary tract infections on the basis of the available evidence, taking into account guidance from the National Institute for Health and Care Excellence (NICE) where available. NICE guidance is always evidence based, adhering to the latest clinical thinking and research to determine the best treatment for patients.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:26:35 answering member 4455 label Biography information for Seema Kennedy
tabling member	4523 label Biography information for Catherine West